These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18827856)

  • 21. Regulation of neuronal repair and regeneration through inhibition of oligodendrocyte myelin glycoprotein (OMgp).
    Choudhary P; Gupta S; Shukla R; Gupta A; Pahal S; Singh S
    J Biomol Struct Dyn; 2022; 40(24):13936-13952. PubMed ID: 34787055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of the Rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats.
    Wu BQ; Bi ZG; Qi Q
    Chin Med J (Engl); 2013; 126(19):3723-7. PubMed ID: 24112171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility.
    Abbhi V; Piplani P
    Curr Med Chem; 2020; 27(14):2222-2256. PubMed ID: 30378487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro.
    Jia XF; Ye F; Wang YB; Feng DX
    Neural Regen Res; 2016 Jun; 11(6):983-7. PubMed ID: 27482229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the Rho signaling pathway improves neurite outgrowth and neuronal differentiation of mouse neural stem cells.
    Gu H; Yu SP; Gutekunst CA; Gross RE; Wei L
    Int J Physiol Pathophysiol Pharmacol; 2013; 5(1):11-20. PubMed ID: 23525456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
    J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho kinase, a promising drug target for neurological disorders.
    Mueller BK; Mack H; Teusch N
    Nat Rev Drug Discov; 2005 May; 4(5):387-98. PubMed ID: 15864268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1.
    Niederöst B; Oertle T; Fritsche J; McKinney RA; Bandtlow CE
    J Neurosci; 2002 Dec; 22(23):10368-76. PubMed ID: 12451136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nogo: a molecular determinant of axonal growth and regeneration.
    Grandpré T; Strittmatter SM
    Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury.
    Holmberg E; Nordstrom T; Gross M; Kluge B; Zhang SX; Doolen S
    J Neurotrauma; 2006 Sep; 23(9):1366-78. PubMed ID: 16958588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
    Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy strategies for spinal cord injury.
    Wang YT; Lu XM; Chen KT; Shu YH; Qiu CH
    Curr Pharm Biotechnol; 2015; 16(6):492-505. PubMed ID: 25860061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates.
    Borisoff JF; Chan CC; Hiebert GW; Oschipok L; Robertson GS; Zamboni R; Steeves JD; Tetzlaff W
    Mol Cell Neurosci; 2003 Mar; 22(3):405-16. PubMed ID: 12691741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ROCK inhibition promotes adult retinal ganglion cell neurite outgrowth only in the presence of growth promoting factors.
    Ahmed Z; Berry M; Logan A
    Mol Cell Neurosci; 2009 Oct; 42(2):128-33. PubMed ID: 19524675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders.
    Chong CM; Ai N; Lee SM
    Curr Drug Targets; 2017; 18(4):455-462. PubMed ID: 27033194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar.
    Monnier PP; Sierra A; Schwab JM; Henke-Fahle S; Mueller BK
    Mol Cell Neurosci; 2003 Mar; 22(3):319-30. PubMed ID: 12691734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
    Yang G; Tang WY
    Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Rho kinase pathway in chondroitin sulfate proteoglycan-mediated inhibition of neurite outgrowth in PC12 cells.
    Gopalakrishnan SM; Teusch N; Imhof C; Bakker MH; Schurdak M; Burns DJ; Warrior U
    J Neurosci Res; 2008 Aug; 86(10):2214-26. PubMed ID: 18438921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.